Royalty Pharma plc (RPRX)
USD 24.47
(-2.59%)
USD 24.47
(-2.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.35 Billion | 2.23 Billion | 2.28 Billion | 2.12 Billion | 1.81 Billion | 1.79 Billion |
| Cost of Revenue | 560.65 Million | 5.67 Million | 22.99 Million | 88.11 Million | 1.01 Billion | 135.96 Million |
| Gross Profit | 1.79 Billion | 2.23 Billion | 2.26 Billion | 2.03 Billion | 794.93 Million | 1.65 Billion |
| Operating Expenses | 862.4 Million | 1.31 Billion | 858.74 Million | 527 Million | -808.92 Million | 430.44 Million |
| Selling, General and Administrative Expenses | 249.74 Million | 227.3 Million | 182.82 Million | 182 Million | 103.43 Million | 61.9 Million |
| Research and Development Expenses | 52 Million | 177.1 Million | 200.08 Million | 26 Million | 83.03 Million | 392.6 Million |
| Other Expenses | - | 909.91 Million | 475.83 Million | 319 Million | -995.39 Million | -1.51 Million |
| Cost and Expenses | 862.4 Million | 1.31 Billion | 858.74 Million | 527 Million | -808.92 Million | 430.44 Million |
| Operating Income | 1.49 Billion | 977.49 Million | 1.43 Billion | 1.59 Billion | 2.62 Billion | 1.36 Billion |
| Interest Expense | 187.18 Million | 187.96 Million | 166.14 Million | 157 Million | 268.57 Million | 279.95 Million |
| Income Tax Expense | - | 187.23 Million | 762.44 Million | 1.14 Billion | 349.33 Million | 433.36 Million |
| Earnings before Tax | 1.7 Billion | 230.06 Million | 1.24 Billion | 1.7 Billion | 2.46 Billion | 1.51 Billion |
| Net Income | 1.13 Billion | 42.83 Million | 478.75 Million | 495.19 Million | 2.34 Billion | 1.37 Billion |
| Earnings Per Share Basic | 3.41 | 0.10 | 1.15 | 1.32 | 6.42 | 3.89 |
| Earnings Per Share Diluted | 2.53 | 0.10 | 1.15 | 1.32 | 6.42 | 3.89 |
| Weighted Average Shares Outstanding | 447.6 Million | 437.96 Million | 414.79 Million | 375.44 Million | 365.89 Million | 354.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 602.9 Million | 437.97 Million | 414.8 Million | 375.45 Million | 365.89 Million | 354.17 Million |
| Gross Margin | 0.76 | 1.00 | 0.99 | 0.96 | 0.44 | 0.92 |
| EBIT Margin | 0.80 | 0.44 | 0.65 | 0.89 | 1.45 | 0.79 |
| Profit Margin | 0.48 | 0.02 | 0.21 | 0.23 | 1.29 | 0.77 |
| EBITDA | 1.88 Billion | 928.56 Million | 1.45 Billion | 1.68 Billion | 2.64 Billion | 1.39 Billion |
| Earnings Before Tax Margin | 0.63 | 0.44 | 0.62 | 0.75 | 1.45 | 0.76 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 537.26 Million | 567.97 Million | 2.35 Billion | 596 Million | 536.31 Million | 538.2 Million |
| Cost of Revenue | 6 Million | 583.6 Million | 560.65 Million | 76.51 Million | 277.13 Million | 241.22 Million |
| Gross Profit | 531.26 Million | -15.62 Million | 1.79 Billion | 519.48 Million | 259.17 Million | 296.97 Million |
| Operating Expenses | 267.63 Million | 641.75 Million | 862.4 Million | -17 Million | 384.87 Million | 289.36 Million |
| Selling, General and Administrative Expenses | 54.7 Million | 57.65 Million | - | 59 Million | 57.23 Million | 47.63 Million |
| Research and Development Expenses | 500 Thousand | 500 Thousand | - | 1 Million | 50.5 Million | 500 Thousand |
| Other Expenses | -212.42 Million | -583.6 Million | -560.65 Million | 77 Million | -1.7 Million | 1.09 Million |
| Cost and Expenses | 267.63 Million | 641.75 Million | 862.4 Million | -17 Million | 384.87 Million | 289.36 Million |
| Operating Income | 269.63 Million | -73.77 Million | 1.49 Billion | 613 Million | 151.44 Million | 248.84 Million |
| Interest Expense | 49.01 Million | 44.23 Million | 187.18 Million | 47 Million | 46.03 Million | 46.94 Million |
| Income Tax Expense | 92.37 Million | -9.05 Million | 565.25 Million | 223 Million | 49.96 Million | 123.71 Million |
| Earnings before Tax | 194.37 Million | -4.27 Million | 1.7 Billion | 718 Million | 122.07 Million | 351.33 Million |
| Net Income | 102 Million | 4.77 Million | 1.13 Billion | 494.34 Million | 72.11 Million | 227.62 Million |
| Earnings Per Share Basic | 0.23 | 0.01 | - | 1.11 | 0.16 | 0.51 |
| Earnings Per Share Diluted | 0.23 | 0.01 | - | 1.11 | 0.16 | 0.50 |
| Weighted Average Shares Outstanding | 451.02 Million | 448.62 Million | 447.6 Million | 446.56 Million | 448.43 Million | 450.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 596.91 Million | 597.47 Million | 602.9 Million | 446.56 Million | 601.13 Million | 605.86 Million |
| Gross Margin | 0.99 | -0.03 | 0.76 | 0.87 | 0.48 | 0.55 |
| EBIT Margin | 0.50 | -0.13 | - | 1.03 | 0.31 | 0.51 |
| Profit Margin | 0.19 | 0.01 | 0.48 | 0.83 | 0.13 | 0.42 |
| EBITDA | 269.63 Million | -73.77 Million | - | 613 Million | 167.94 Million | 274.81 Million |
| Earnings Before Tax Margin | 0.50 | -0.13 | 0.63 | 1.03 | 0.28 | 0.46 |
RADL3
AMC
WLE
000059
OAU
0K3S